Marimed (MRMD) COO Timothy Shaw Receives RSU Shares

What Happened
Timothy Shaw, Chief Operating Officer of Marimed Inc. (MRMD), had 42,656 restricted stock units (RSUs) convert to common shares on July 15, 2026 (reported as exercise/conversion of derivatives). Of those, 14,781 shares were withheld by the issuer to satisfy tax-withholding obligations (reported disposition, code F) for a reported cash value of $979. The filing also shows the related derivative units were canceled/disposed. Net to Shaw’s beneficial holdings from this vesting event: +27,875 shares (42,656 acquired − 14,781 withheld).

Key Details

• Transaction date: July 15, 2026; filing date: July 17, 2026.
• Entries reported: 42,656 shares acquired via conversion (code M) at $0.00; 14,781 shares withheld for taxes (code F) at $0.07, reported value $979; derivative units disposed/canceled (code M) showing $0 value.
• Net increase in shares held by the reporting person from this vesting: 27,875 shares. The filing does not state total shares owned after the transaction.
• Relevant footnotes: RSUs convert one-for-one into common stock; withheld shares satisfy tax withholding; the RSU grant was dated April 15, 2026, with remaining vesting in three equal installments on Oct 15, 2026; Jan 15, 2027; and Apr 15, 2027. A trust disclosure notes certain shares held in trust for the reporting person’s children, with a disclaimer of beneficial ownership.
• Timeliness: Report filed two days after the transaction date (no late-filing flag in the report).

Context
This was primarily an RSU vesting/conversion event, not an open-market buy or sale. The withholding of shares to cover taxes is a routine administrative step (similar to a cashless net settlement) and does not necessarily indicate a change in the insider’s market view. The filing shows a net acquisition of shares by the insider following the vesting.